Vicor Technologies, Inc. (OTCBB: VCRT) – An Overview of Vicor’s PD2i® Technology, its Family and its Functions

Filed In: Vicor Technologies, VCRT, PD2i, FDA, Medical Equipment, Diagnostic technology, PD2i Analyzer, PD2i CA, PD2i VS

Vicor Technologies, Inc. is a company that creates innovative, non-invasive diagnostics based on its patented PD2i® nonlinear algorithm, a new vital sign which accurately determines the likelihood of pathological events in specific populations.

At present, Vicor is in the process of aggressively commercializing the company’s first three products which are the PD2i Analyzer™ , to measure heart rate variability in patients at rest; the PD2i CA™ (Cardiac Analyzer), to identify cardiovascular disease patients at risk of death from arrhythmia or pump failure; and the PD2i VS™ (Vital Sign), which quickly evaluates critically-injured patients to improve triage and survivability.

Vicor Company Website: http://www.vicortech.com/
Stockguru’s Profile on Vicor: http://stockguru.com//about/vcrt/

VCRT Disclosure: StockGuru entered into an investor relations consulting and market awareness contract with VCRT. We are also doing a video on ShareholderVision.com that will be released shortly.  The Company will pay us a total of seventy two hundred dollars and fifty thousand shares of restricted 144 stock for the period ending August 31, 2011. We still hold hold these shares.  To avoid all potential conflicts of interest, we never sell shares into the open market during an active market awareness or investor relations program. This means that as we release new information about a particular client company either on our site or otherwise authored by us, you can be confident we are not selling shares at the same time. StockGuru is not a registered investment adviser or a broker/dealer. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable.  In early 2010, the Company paid us seventy two hundred dollars and fifty thousand shares of restricted 144 stock for a prior round of coverage that ended.   In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk. StockGuru – 1601 Berwick Drive – McKinney, Texas 75070 – (469) 252-3031.